Ruxolitinib: a targeted treatment option for patients with polycythemia vera

Kris Vaddi,1 Srdan Verstovsek,2 Jean-Jacques Kiladjian3 1Drug Discovery, Incyte Corporation, Wilmington, DE, 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 3Clinical Investigations Center, Hôpital Saint-Louis et Université Paris Did...

Full description

Saved in:
Bibliographic Details
Main Authors: Vaddi K, Verstovsek S, Kiladjian JJ
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
Online Access:https://doaj.org/article/e9b74c39000f4fbfa80a712811c8f25f
Tags: Add Tag
No Tags, Be the first to tag this record!